Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

15,499 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Impact of neoadjuvant relugolix on patient-reported sexual function and bother.
Hsueh JY, Gallagher L, Koh MJ, Eden S, Shah S, Wells M, Danner M, Zwart A, Ayoob M, Kumar D, Leger P, Dawson NA, Suy S, Rubin R, Collins SP. Hsueh JY, et al. Among authors: shah s. Front Oncol. 2024 Apr 11;14:1377103. doi: 10.3389/fonc.2024.1377103. eCollection 2024. Front Oncol. 2024. PMID: 38665954 Free PMC article.
Urinary Morbidity in Men Treated With Stereotactic Body Radiation Therapy (SBRT) for Localized Prostate Cancer Following Transurethral Resection of the Prostate (TURP).
Pepin A, Aghdam N, Shah S, Kataria S, Tsou H Jr, Datta S, Danner M, Ayoob M, Yung T, Lei S, Gurka M, Collins BT, Krishnan P, Suy S, Hankins R, Lynch JH, Collins SP. Pepin A, et al. Among authors: shah s. Front Oncol. 2020 May 5;10:555. doi: 10.3389/fonc.2020.00555. eCollection 2020. Front Oncol. 2020. PMID: 32432033 Free PMC article.
Early biochemical outcomes following neoadjuvant/adjuvant relugolix with stereotactic body radiation therapy for intermediate to high risk prostate cancer.
Gallagher L, Xiao J, Hsueh J, Shah S, Danner M, Zwart A, Ayoob M, Yung T, Simpson T, Fallick M, Kumar D, Leger P, Dawson NA, Suy S, Collins SP. Gallagher L, et al. Among authors: shah s. Front Oncol. 2023 Oct 17;13:1289249. doi: 10.3389/fonc.2023.1289249. eCollection 2023. Front Oncol. 2023. PMID: 37916156 Free PMC article.
Integrated approach of white analytical chemistry and design of experiments to microwave-assisted sensitive and eco-friendly spectrofluorimetric estimation of mirabegron using 4-chloro-7-nitrobezofuran as biosensing fluorescent probe.
Prajapati P, Patel K, Patel A, Shakar Pulusu V, Haque A, Ahmad S, Shah S. Prajapati P, et al. Among authors: shah s. Spectrochim Acta A Mol Biomol Spectrosc. 2024 May 24;319:124521. doi: 10.1016/j.saa.2024.124521. Online ahead of print. Spectrochim Acta A Mol Biomol Spectrosc. 2024. PMID: 38830329
Five historical innovations that have shaped modern otolaryngological surgery.
Patel R, Acharya R, Shah S, Desai C, Raveshia D, Panesar H, Patel N, Mcconaghie G, Cain DC, Parmar D, Banerjee R, Singh R. Patel R, et al. Among authors: shah s. J Perioper Pract. 2024 Jun 3:17504589241244996. doi: 10.1177/17504589241244996. Online ahead of print. J Perioper Pract. 2024. PMID: 38828977
Advancing Lifestyle Medicine in New York City's Public Health Care System.
Babich JS, McMacken M, Correa L, Polito-Moller K, Chen K, Adams E, Morgenstern S, Katz M, Long TG, Joshi S, Wallach AB, Shah S, Boas R. Babich JS, et al. Among authors: shah s. Mayo Clin Proc Innov Qual Outcomes. 2024 May 21;8(3):279-292. doi: 10.1016/j.mayocpiqo.2024.01.005. eCollection 2024 Jun. Mayo Clin Proc Innov Qual Outcomes. 2024. PMID: 38828080 Free PMC article. Review.
15,499 results
You have reached the last available page of results. Please see the User Guide for more information.